Clinical Trial Update: Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating lymphodepletion strategies to improve outcomes in patients with diffuse large B-cell lymphoma treated with Kymriah (tisagenlecleuc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Kymriah (tisagenlecleucel)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 1 | Status: WITHDRAWN